| Company/Division name | Autolus Therapeutics |
| Parent company | Autolus Therapeutics |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 170 |
| Year reshoring announced: | 2019 |
| Year reshoring implemented or to be implemented: | 2021 |
| Country(ies) from which reshored: | United Kingdom |
| City reshored to: | Rockville |
| State(s) reshored to: | MD |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | advanced T-cell therapies (cancer treatment) |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, Skilled workforce availability/training |
